The new MALDI Tissuetyper based on the rapifleX instrument re-defines the key performance measures for MALDI imaging and allows for completely new projects and measurement strategies. The rapifleX ...

MALDI-2 Increases Small Molecule Sensitivity by One or Two Orders of Magnitude New prm-PASEF Workflow for Translational 4D Proteomics Large-Scale, High-Precision Peptide CCS Measurements for Deep ...

Bruker Corporation BRKR recently announced the launch of the neofleX Imaging Profiler for mass spectrometry-based tissue imaging at the 72nd ASMS meeting. The novel, high-performance MALDI-TOF/TOF ...

Bruker announced its new MALDI PharmaPulse 2.0 solution (MPP 2.0), which enhances the automation capabilities of the rapifleX MALDI-TOF mass spectrometer, with its proprietary scanning 10 kHz ...

Innovative timsTOF platform combined with extreme MALDI PharmaPulse speed and robustness for unbiased, deep HTS and uHTS (ultra-high-throughput screening) Trapped Ion Mobility Spectrometry (TIMS): ...

Bruker Corporation BRKR launched the new MALDI Biotyper sirius system for all previously FDA-approved assays and research-use-only (RUO) MALDI Biotyper (MBT) reference libraries at the ASM Microbe ...

Mass spectrometry has long been recognized as one of the leading analytical tools for the rapid characterization of biological macromolecules. The imaging function of mass spectrometry combines the ...

BALTIMORE--(BUSINESS WIRE)--At the 62 nd ASMS Conference on Mass Spectrometry and Allied Topics today, Bruker Corporation (NASDAQ:BRKR) today announced mass spectrometry-based product introductions ...

At the virtual ASMS 2020 Reboot conference, Bruker Corporation today announces a major advance in matrix-assisted laser desorption ionization (MALDI) with the launch of the world’s first commercial ...